From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery
Year: 2026
Type: article
Abstract: Unlabelled: Pharmaceutical development is typically a long and arduous process, but advances in artificial intelligence may help streamline each stage of this pipeline. In this News and Perspectives article, JMIR Correspondent Benedette Cuffari reports on recent innovations and their potential implications for drug discovery.
DOI: 10.2196/101366
Author: Benedette Cuffari
Language: English
Subfield: Computational Theory and Mathematics
Field: Computer Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $2,950
OpenAlex ID: W7162788928
